The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
The global Hirudin market was valued at US$ 3975 million in 2023 and is anticipated to reach US$ 4934.7 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.
Report Scope
The Hirudin market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hirudin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hirudin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
Segment by Type
Natural Hirudin
Recombinant Hirudin
Segment by Application
Thrombosis Disease
Tumor Disease
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hirudin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Hirudin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
The global Hirudin market was valued at US$ 3975 million in 2023 and is anticipated to reach US$ 4934.7 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.
Report Scope
The Hirudin market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hirudin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hirudin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
Segment by Type
Natural Hirudin
Recombinant Hirudin
Segment by Application
Thrombosis Disease
Tumor Disease
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hirudin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Hirudin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Hirudin Market Overview
1.1 Product Definition
1.2 Hirudin Segment by Type
1.2.1 Global Hirudin Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Natural Hirudin
1.2.3 Recombinant Hirudin
1.3 Hirudin Segment by Application
1.3.1 Global Hirudin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Hirudin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Hirudin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Hirudin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Hirudin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Hirudin Production Market Share by Manufacturers (2019-2024)
2.2 Global Hirudin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Hirudin, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Hirudin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Hirudin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Hirudin, Product Offered and Application
2.8 Global Key Manufacturers of Hirudin, Date of Enter into This Industry
2.9 Hirudin Market Competitive Situation and Trends
2.9.1 Hirudin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Hirudin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Hirudin Production by Region
3.1 Global Hirudin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Hirudin Production Value by Region (2019-2030)
3.2.1 Global Hirudin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Hirudin by Region (2025-2030)
3.3 Global Hirudin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Hirudin Production by Region (2019-2030)
3.4.1 Global Hirudin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Hirudin by Region (2025-2030)
3.5 Global Hirudin Market Price Analysis by Region (2019-2024)
3.6 Global Hirudin Production and Value, Year-over-Year Growth
3.6.1 North America Hirudin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Hirudin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Hirudin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Hirudin Production Value Estimates and Forecasts (2019-2030)
4 Hirudin Consumption by Region
4.1 Global Hirudin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Hirudin Consumption by Region (2019-2030)
4.2.1 Global Hirudin Consumption by Region (2019-2024)
4.2.2 Global Hirudin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Hirudin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Hirudin Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Hirudin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Hirudin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Hirudin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Hirudin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Hirudin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Hirudin Production by Type (2019-2030)
5.1.1 Global Hirudin Production by Type (2019-2024)
5.1.2 Global Hirudin Production by Type (2025-2030)
5.1.3 Global Hirudin Production Market Share by Type (2019-2030)
5.2 Global Hirudin Production Value by Type (2019-2030)
5.2.1 Global Hirudin Production Value by Type (2019-2024)
5.2.2 Global Hirudin Production Value by Type (2025-2030)
5.2.3 Global Hirudin Production Value Market Share by Type (2019-2030)
5.3 Global Hirudin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Hirudin Production by Application (2019-2030)
6.1.1 Global Hirudin Production by Application (2019-2024)
6.1.2 Global Hirudin Production by Application (2025-2030)
6.1.3 Global Hirudin Production Market Share by Application (2019-2030)
6.2 Global Hirudin Production Value by Application (2019-2030)
6.2.1 Global Hirudin Production Value by Application (2019-2024)
6.2.2 Global Hirudin Production Value by Application (2025-2030)
6.2.3 Global Hirudin Production Value Market Share by Application (2019-2030)
6.3 Global Hirudin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 The Medicines Company
7.1.1 The Medicines Company Hirudin Corporation Information
7.1.2 The Medicines Company Hirudin Product Portfolio
7.1.3 The Medicines Company Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 The Medicines Company Main Business and Markets Served
7.1.5 The Medicines Company Recent Developments/Updates
7.2 Keyken
7.2.1 Keyken Hirudin Corporation Information
7.2.2 Keyken Hirudin Product Portfolio
7.2.3 Keyken Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Keyken Main Business and Markets Served
7.2.5 Keyken Recent Developments/Updates
7.3 Minapharm
7.3.1 Minapharm Hirudin Corporation Information
7.3.2 Minapharm Hirudin Product Portfolio
7.3.3 Minapharm Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Minapharm Main Business and Markets Served
7.3.5 Minapharm Recent Developments/Updates
7.4 Abbott
7.4.1 Abbott Hirudin Corporation Information
7.4.2 Abbott Hirudin Product Portfolio
7.4.3 Abbott Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Abbott Main Business and Markets Served
7.4.5 Abbott Recent Developments/Updates
7.5 SALUBRIS
7.5.1 SALUBRIS Hirudin Corporation Information
7.5.2 SALUBRIS Hirudin Product Portfolio
7.5.3 SALUBRIS Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 SALUBRIS Main Business and Markets Served
7.5.5 SALUBRIS Recent Developments/Updates
7.6 Pfizer, Inc
7.6.1 Pfizer, Inc Hirudin Corporation Information
7.6.2 Pfizer, Inc Hirudin Product Portfolio
7.6.3 Pfizer, Inc Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Pfizer, Inc Main Business and Markets Served
7.6.5 Pfizer, Inc Recent Developments/Updates
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Hirudin Corporation Information
7.7.2 Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio
7.7.3 Teva Pharmaceutical Industries Ltd Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served
7.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.8 DUOPUTAI
7.8.1 DUOPUTAI Hirudin Corporation Information
7.8.2 DUOPUTAI Hirudin Product Portfolio
7.8.3 DUOPUTAI Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 DUOPUTAI Main Business and Markets Served
7.7.5 DUOPUTAI Recent Developments/Updates
7.9 Pentapharm
7.9.1 Pentapharm Hirudin Corporation Information
7.9.2 Pentapharm Hirudin Product Portfolio
7.9.3 Pentapharm Hirudin Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Pentapharm Main Business and Markets Served
7.9.5 Pentapharm Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Hirudin Industry Chain Analysis
8.2 Hirudin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Hirudin Production Mode & Process
8.4 Hirudin Sales and Marketing
8.4.1 Hirudin Sales Channels
8.4.2 Hirudin Distributors
8.5 Hirudin Customers
9 Hirudin Market Dynamics
9.1 Hirudin Industry Trends
9.2 Hirudin Market Drivers
9.3 Hirudin Market Challenges
9.4 Hirudin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
